Cases & Deals

Stallergenes Greer obtains revolving credit facility from UBS

Clients Stallergenes Greer plc

Jones Day represented Stallergenes Greer plc, a global biopharmaceutical company specializing in treatments for respiratory allergies, in connection with a new revolving credit facility provided by UBS Switzerland AG.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.